Finance

Beta
Lists
NAGE:NASDAQ
Niagen Bioscience Inc
$3.86
+0.52%
(+0.020) 1D
$3.85
-0.18% (-0.0069)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
$3.85
High
$3.94
Low
$3.80
Mkt. cap
307.85M
Avg. vol.
956.83K
Volume
1.91M
52-wk high
$14.69
52-wk low
$3.56
Beta
2.17
Shares outstanding
79.64M
No. of employees
117
Open
$3.85
High
$3.94
Low
$3.80
Mkt. cap
307.85M
Avg. vol.
956.83K
Volume
1.91M
52-wk high
$14.69
52-wk low
$3.56
Beta
2.17
Shares outstanding
79.64M
No. of employees
117
News stories
From sources across the web
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersLos Angeles, California, United States
SectorPersonal care products
Websiteniagenbioscience.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.12M
33.99M
33.84M
31.47M
Cost of goods sold
10.89M
12.06M
12.14M
11.50M
Cost of revenue
10.89M
12.06M
12.14M
11.50M
Research and development expenses
1.57M
1.80M
1.71M
1.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.47M
15.90M
17.89M
16.92M
Operating expense
17.04M
17.69M
19.60M
18.40M
Total operating expenses
27.93M
29.75M
31.74M
29.90M
Operating income
3.18M
4.24M
2.10M
1.58M
Other non operating income
-
-
-214.00K
-
EBT including unusual items
3.74M
4.80M
4.42M
6.74M
EBT excluding unusual items
3.74M
4.80M
2.44M
1.95M
Income tax expense
128.00K
222.00K
292.00K
417.00K
Effective tax rate
3.43%
4.62%
6.60%
6.19%
Other operating expenses
-
-
-
-
Net income
3.61M
4.58M
4.13M
6.32M
Net profit margin
11.60%
13.47%
12.21%
20.07%
Earnings per share
0.04
0.05
0.03
0.02
Interest and investment income
552.00K
564.00K
552.00K
375.00K
Interest expense
-
-
-
-
Net interest expenses
552.00K
564.00K
552.00K
375.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.38M
4.43M
2.30M
1.87M
Gain or loss from assets sale
-
-
-
-4.78M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer